Pediatric arterial thrombosis: A single-institution cohort study of patient characteristics and thrombosis outcomes

Pediatr Blood Cancer. 2024 Jan;71(1):e30756. doi: 10.1002/pbc.30756. Epub 2023 Oct 30.

Abstract

Background: Arterial thrombosis (AT) is an increasingly recognized complication in pediatrics. Consensus clinical practice guidelines suggest immediate removal of the indwelling arterial catheter and a short course (5-7 days) of anticoagulation. The optimal duration and modality of antithrombotic therapy in children are yet to be determined.

Aims: Describe treatment patterns and outcomes in pediatric patients with AT and explore predictors for complete thrombus resolution or long-term complications.

Methods: Single-institution retrospective study. Patients were identified by ICD-9 and ICD-10 codes for the diagnosis of AT or reports of AT on ultrasound from January 1, 2012, to October 1, 2022. Descriptive and logistic regression analyses were used.

Results: 101 patients were included. The median age was 2.2 months. The most common underlying diagnoses were congenital heart disease (39.6%) and infection (22.8%). A majority of patients had symptomatic thrombosis in an extremity, and 78% were catheter-associated. 81% of patients received anticoagulation with a median duration of 35 days. Out of the 70 patients who were treated with anticoagulation alone and had a follow-up imaging, 70% had complete resolution after 90 days of anticoagulation. No clear predictors of complete resolution were identified. Eighteen patients had long-term sequelae secondary to arterial insufficiency. Those with infection-associated AT were more likely to have long-term complications. The major and clinically relevant non-major bleeding rate was 11%.

Conclusion: Duration of anticoagulation was widely variable, and 70% of patients achieved complete resolution by 90 days of anticoagulation. A significant proportion of patients developed long-term sequelae secondary to arterial insufficiency. Sepsis/infection at the time of diagnosis with AT was more likely to be associated with long-term complications.

Keywords: Artery; children; infection; thrombosis; treatment.

MeSH terms

  • Anticoagulants / therapeutic use
  • Arterial Occlusive Diseases* / complications
  • Catheterization / adverse effects
  • Child
  • Cohort Studies
  • Humans
  • Infant
  • Retrospective Studies
  • Thrombosis* / drug therapy
  • Thrombosis* / etiology
  • Treatment Outcome

Substances

  • Anticoagulants